Else Nutrition Holdings Inc. is poised for significant advantages following recent developments from the U.S. Food and Drug Administration (FDA) regarding infant formula protein...
Stoke Therapeutics, Inc., based in Bedford, Massachusetts, has announced significant updates regarding its ongoing clinical trial for zorevunersen, a potential treatment for Dravet syndrome....